nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0372	0.0382	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—P2RY11—narcolepsy	0.0272	0.0279	CbGpPWpGaD
Bupranolol—Clenbuterol—TNF—narcolepsy	0.0266	1	CrCbGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0221	0.0227	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—HTR2A—narcolepsy	0.0221	0.0227	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0216	0.0222	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0202	0.0208	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0185	0.019	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0161	0.0166	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0158	0.0162	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0156	0.0161	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0156	0.0161	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0151	0.0155	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0134	0.0138	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0134	0.0138	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0131	0.0135	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0129	0.0133	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0128	0.0132	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—NPS—narcolepsy	0.0127	0.0131	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.011	0.0113	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.011	0.0113	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0108	0.0111	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HCRTR2—narcolepsy	0.0102	0.0105	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HCRTR1—narcolepsy	0.0102	0.0105	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—P2RY11—narcolepsy	0.00986	0.0101	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00981	0.0101	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00929	0.00954	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00929	0.00954	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00909	0.00933	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00909	0.00933	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00897	0.00922	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00878	0.00901	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00854	0.00877	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HCRT—narcolepsy	0.00838	0.00861	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00834	0.00857	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00796	0.00818	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00796	0.00818	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00778	0.008	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00778	0.008	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00769	0.0079	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.00755	0.00775	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00752	0.00772	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—PENK—narcolepsy	0.00747	0.00768	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.00738	0.00758	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00732	0.00752	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00654	0.00671	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00639	0.00657	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—TRH—narcolepsy	0.00635	0.00653	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00606	0.00623	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00606	0.00623	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.00606	0.00623	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.00606	0.00623	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.00593	0.00609	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.00593	0.00609	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.00585	0.00601	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00582	0.00598	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00577	0.00593	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00577	0.00593	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.00573	0.00588	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0057	0.00585	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.00569	0.00584	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—P2RY11—narcolepsy	0.00557	0.00572	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HRH3—narcolepsy	0.00557	0.00572	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HCRTR2—narcolepsy	0.00524	0.00538	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HCRTR1—narcolepsy	0.00524	0.00538	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00507	0.00521	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—P2RY11—narcolepsy	0.00506	0.0052	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00498	0.00511	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00496	0.00509	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00495	0.00509	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00487	0.005	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00484	0.00498	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HCRT—narcolepsy	0.00474	0.00487	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—NPS—narcolepsy	0.00462	0.00474	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—TAC1—narcolepsy	0.00462	0.00474	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00444	0.00456	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00434	0.00446	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00434	0.00446	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HCRT—narcolepsy	0.0043	0.00442	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00426	0.00437	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00425	0.00436	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PENK—narcolepsy	0.00422	0.00434	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PENK—narcolepsy	0.00384	0.00394	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00377	0.00387	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00369	0.00379	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00365	0.00375	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0036	0.0037	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0036	0.0037	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TRH—narcolepsy	0.00359	0.00369	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00352	0.00362	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00352	0.00362	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00342	0.00352	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00342	0.00352	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00335	0.00344	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00335	0.00344	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00331	0.0034	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00331	0.0034	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TRH—narcolepsy	0.00326	0.00335	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00324	0.00332	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00324	0.00332	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HRH3—narcolepsy	0.00315	0.00323	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00311	0.00319	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00311	0.00319	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HCRTR2—narcolepsy	0.0031	0.00318	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HCRTR1—narcolepsy	0.0031	0.00318	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00304	0.00313	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00304	0.00313	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.003	0.00309	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—P2RY11—narcolepsy	0.00299	0.00307	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00294	0.00302	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRH3—narcolepsy	0.00286	0.00294	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00281	0.00289	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—narcolepsy	0.00278	0.00285	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00275	0.00283	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00274	0.00282	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00274	0.00282	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00268	0.00275	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00268	0.00275	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TAC1—narcolepsy	0.00261	0.00268	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—NPS—narcolepsy	0.00261	0.00268	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00255	0.00262	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HCRT—narcolepsy	0.00254	0.00261	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00253	0.0026	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00251	0.00258	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.0025	0.00257	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00247	0.00254	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00245	0.00252	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TAC1—narcolepsy	0.00237	0.00243	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NPS—narcolepsy	0.00237	0.00243	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00228	0.00234	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PENK—narcolepsy	0.00227	0.00233	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00223	0.00229	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00216	0.00222	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00213	0.00219	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00212	0.00218	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00208	0.00214	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00194	0.00199	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TRH—narcolepsy	0.00193	0.00198	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00189	0.00194	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00187	0.00192	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00184	0.00189	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00184	0.00189	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00183	0.00188	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.0018	0.00185	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.0018	0.00185	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00177	0.00182	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00174	0.00178	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.0017	0.00174	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRH3—narcolepsy	0.00169	0.00174	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00166	0.00171	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00165	0.00169	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00161	0.00166	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—narcolepsy	0.00157	0.00161	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00155	0.00159	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00155	0.00159	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00151	0.00156	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00151	0.00156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00151	0.00155	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00148	0.00152	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—narcolepsy	0.00143	0.00146	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00141	0.00144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00141	0.00144	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAC1—narcolepsy	0.0014	0.00144	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NPS—narcolepsy	0.0014	0.00144	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00138	0.00141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00138	0.00141	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00134	0.00138	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00132	0.00135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.00114	0.00117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00112	0.00115	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.001	0.00103	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.000981	0.00101	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.000932	0.000957	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000911	0.000936	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000846	0.000869	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—narcolepsy	0.000842	0.000865	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000831	0.000853	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000831	0.000853	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000828	0.00085	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000813	0.000835	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000813	0.000835	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.0005	0.000513	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000489	0.000502	CbGpPWpGaD
